Investing.com - CVRx (NASDAQ: CVRX) reported second quarter EPS of $-0.56, $0.02 better than the analyst estimate of $-0.58. Revenue for the quarter came in at $9.5M versus the...
Investing.com - CVRx (NASDAQ: CVRX) reported first quarter EPS of $-0.55, $0.02 better than the analyst estimate of $-0.57. Revenue for the quarter came in at $8M versus the...
CVRx, Inc. (CVRX) reported Q4 EPS of ($0.51), $0.05 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $7.18 million versus the consensus estimate of...
Investing.com - CVRx (NASDAQ: CVRX) reported fourth quarter EPS of $-0.51, $0.05 better than the analyst estimate of $-0.56. Revenue for the quarter came in at $7.18M versus the...
Investing.com - CVRx reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations. CVRx announced earnings per share of $-0.48...
CVRx, Inc. (CVRX) reported Q2 EPS of ($0.54), in-line with the analyst estimate of ($0.54). Revenue for the quarter came in at $5 million versus the consensus estimate of $4.77...
CVRx, Inc. (CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients...